Chan Zuckerberg Initiative Announces $3 Billion Investment To Cure All Disease
By Eyder Peralta,
NPR
| 09. 21. 2016
The Chan Zuckerberg Initiative just announced one of its biggest investments to date: It is ponying up more than $3 billion to kickstart "Chan Zuckerberg Science," an initiative that plans to bring together multidisciplinary teams of scientists in an effort to prevent, cure or manage "all diseases in our children's lifetime."
If you remember, at the end of last year, Facebook founder Mark Zuckerberg and his wife, Priscilla Chan, promised to give away almost all of their $45 billion fortune during their lifetime. This project is a part of that promise.
Chan and Zuckerberg made the announcement Wednesday during an event in San Francisco that was streamed live on Facebook.
Venture Beat reports:
" 'That doesn't mean that no one will ever get sick,' Mark Zuckerberg later said. But the program aims to eventually make all diseases treatable — or at least easily manageable — by the end of the 21st century. 'Our society spends 50x more treating people who are sick than on finding cures. We can do better than that,' said Zuckerberg.
"At a distance, the project...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Antonio Regalado, MIT Technology Review | 06.05.2025
Brian Armstrong, the billionaire CEO of the cryptocurrency exchange Coinbase, says he’s ready to fund a US startup focused on gene-editing human embryos. If he goes forward, it would be the first major commercial investment in one of medicine’s most...
